Basal Cell Carcinoma
Basal cell carcinoma (BCC) is the most common skin cancer, with over 3 million U.S. cases annually. It rarely metastasizes but can cause significant local tissue destruction.
Symptoms
Pearly or translucent bump with visible blood vessels, a non-healing sore that bleeds and crusts, or a flat scar-like waxy area. Most common on the head, neck, and sun-exposed areas.
Causes and risk
Cumulative UV exposure is the primary cause. Fair skin, sunburn history, older age, immunosuppression, and prior BCCs are major risk factors.
How it is evaluated
Biopsy is required for confirmation. We determine BCC subtype and location to guide treatment. High-risk features include size, facial location, and aggressive histology.
Treatment
Small low-risk BCCs: electrodesiccation and curettage or excision. Facial or high-risk BCCs: Mohs surgery for superior cure rates. Topical imiquimod for superficial BCCs. Our Chicago team coordinates biopsy, treatment, and surveillance.